KROS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 11:42):
Our systems believe the stock currently is overvalued by -0.05% compare to its pairs and should correct downwards.

Stats
Today's Volume	57 791
Average Volume	312 979
Market Cap	1.62B
EPS	$-1.460 ( Q1 \| 2024-05-08 )
Next earnings date	( $-1.270 ) 2024-08-05
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-8.74 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0940 (0.21%)

AADI -3.53%

ABCL 1.51%

ABCM 0.04%

ABEO -2.14%

ABIO -2.23%

ABOS 0.00%

ABSI 1.70%

ABUS -2.30%

ABVX -2.03%

ACAD -0.64%

ACER -17.95%

ACET -5.10%

ACGN 1.29%

ACHL -2.22%

ACHV -1.29%

ACIU -1.75%

ACLX 0.26%

ACRV -5.61%

ACST -3.58%

ACXP 1.38%

ADAG 4.64%

ADAP -4.12%

ADGI 0.87%

ADIL 0.54%

ADMA -2.82%

ADPT -0.15%

ADTX -3.47%

ADVM -3.33%

ADXN -1.60%

AEON -3.74%

AEZS -2.51%

AFMD -0.61%

AGEN -3.03%

AGIO -2.48%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -2.27%

AKRO -2.67%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -2.52%

ALEC -1.83%

ALGS -2.06%

ALKS -0.21%

ALLK -8.51%

ALLO -4.63%

ALLR -3.41%

ALNA 3.16%

ALNY 2.27%

ALPN 0.02%

ALPX 0.00%

ALRN 0.33%

ALT -9.51%

ALVR -0.40%

ALXN 0.00%

ALXO -10.88%

ALZN 2.04%

AMRN 0.56%

AMTI -3.13%

ANAB 1.05%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -1.53%

ANPC -3.15%

APGE -1.09%

APGN 8.48%

APGNW 30.65%

APLM -5.01%

APLS 0.17%

APLT -3.84%

APM -2.94%

APOP 0.38%

APRE 0.61%

APTO 6.30%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -4.61%

ARDS -14.23%

ARDX -0.66%

ARGX -1.04%

ARNA 0.00%

ARPO -0.90%

ARQT -1.51%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.50%

ARWR -1.60%

ASLN -5.07%

ASMB -5.83%

ASND -1.45%

ATAI -1.48%

ATHA 5.48%

ATHE 0.55%

ATHX -33.50%

ATNF 0.99%

ATOS 0.97%

ATRA -2.83%

ATXI 1.93%

ATXS -0.89%

AUPH -0.99%

AURA 1.17%

AUTL -2.16%

AVBP -4.23%

AVEO 0.00%

AVIR -0.44%

AVRO -1.41%

AVTE -5.15%

AVTX -1.25%

AVXL -3.09%

AXLA 0.00%

AXSM -1.86%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 1.15%

BCAB 3.27%

BCDA -1.87%

BCDAW -41.77%

BCEL 0.00%

BCLI 5.82%

BCRX 0.99%

BCTX 8.16%

BCTXW -17.41%

BCYC 0.80%

BDRX -4.94%

BDTX -1.06%

BEAM 0.66%

BFRA -2.91%

BGNE -2.99%

BIOR -3.80%

BIVI 4.92%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.89%

BLTE -0.62%

BLU 0.03%

BLUE -0.25%

BMEA -11.31%

BMRN 0.51%

BNOX -2.22%

BNTC -0.42%

BNTX -1.87%

BOLD -8.58%

BOLT 0.72%

BPMC -1.25%

BPTH 1.42%

BPTS -13.47%

BRNS -0.74%

BRTX -2.36%

BTAI 25.23%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.39%

CABA 0.62%

CADL -1.42%

CALA 0.00%

CALC -1.77%

CALT -1.14%

CAPR -2.80%

CARA -0.12%

CARM 10.35%

CASI -1.65%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -6.50%

CCCC -5.41%

CCXI 0.00%

CDAK 0.00%

CDIO -2.20%

CDIOW 24.00%

CDMO -2.95%

CDMOP 0.04%

CDT -12.20%

CDTTW -39.60%

CDTX -1.92%

CDXC 0.41%

CDXS 6.21%

CELC -4.58%

CELU -1.97%

CELUW 11.80%

CERC -1.68%

CERE -1.09%

CERO -4.45%

CEROW -20.21%

CFRX -27.95%

CGEM -2.44%

CGEN -3.87%

CGON -1.56%

CGTX -4.47%

CHMA -6.00%

CHRS 0.32%

CINC 0.00%

CING 2.26%

CINGW 34.95%

CKPT -3.35%

CLBS -16.75%

CLDX -2.29%

CLGN 0.34%

CLLS -4.15%

CLNN 2.42%

CLNNW 0.00%

CLRB 7.41%

CLSD 0.00%

CLSN -0.68%

CLVS 0.00%

CMMB -0.97%

CMND 0.81%

CMPI 0.00%

CMPX -7.19%

CMRA 0.00%

CMRAW 33.33%

CMRX -3.04%

CNCE 0.00%

CNSP -38.46%

CNST 0.00%

CNTA -0.51%

CNTB -2.25%

CNTX -6.85%

COCP -2.00%

COEPW 32.45%

COGT -2.76%

CORT 2.03%

COYA -1.46%

CPRX -1.22%

CRBP -3.34%

CRBU -5.10%

CRDF -1.77%

CRGX 0.47%

CRIS -0.38%

CRNX -6.15%

CRSP 1.17%

CRTX 2.63%

CRVO -2.50%

CRVS 1.82%

CSBR -1.59%

CTCX -1.60%

CTIC 0.06%

CTMX -2.89%

CTNM -0.86%

CTXR 2.01%

CUE 4.50%

CVAC -2.27%

CVKD 0.11%

CWBR 2.80%

CYAD -12.96%

CYCC 10.06%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -1.80%

CYTO -1.82%

DARE 6.33%

DAWN 0.37%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 26.54%

DNLI -1.65%

DNTH -8.21%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -1.21%

DTIL 0.56%

DYAI 10.32%

EARS -1.77%

EDIT -3.02%

EDSA 3.19%

EFTR 3.68%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 7.56%

ELEV -5.81%

ELOX 7.69%

ELTX -0.88%

ELVN -4.45%

ELYM 1.26%

ENGN -4.44%

ENGNW 0.12%

ENLV 2.54%

ENOB 1.79%

ENSC 4.17%

ENTA -0.57%

ENTO -2.47%

ENTX 2.08%

ENVB -0.84%

EPIX -0.31%

EPRX -2.97%

EPZM 0.00%

EQ 0.32%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -0.64%

ETON 2.13%

ETTX 0.00%

EVAX -2.14%

EVGN 3.97%

EVLO 0.00%

EWTX -0.17%

EXAI -0.38%

EXEL -0.36%

EYEG -0.69%

EYEN 1.45%

EYPT 0.00%

FATE -8.06%

FBIO 0.59%

FBIOP 0.92%

FBLG -16.26%

FBRX -0.04%

FDMT -4.52%

FENC -1.29%

FGEN -5.17%

FHTX 1.91%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.74%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.04%

FULC -4.01%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.73%

GANX -1.54%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -4.32%

GHRS -2.16%

GLMD -2.33%

GLPG -2.27%

GLSI 1.67%

GLTO -0.57%

GLUE -2.50%

GLYC -9.70%

GMAB -0.50%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT 0.00%

GNLX 0.88%

GNPX 0.98%

GNTA 3.94%

GOSS -10.05%

GOVX 4.77%

GOVXW -49.04%

GPCR -6.73%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.65%

GRTX 2.57%

GTHX 0.45%

GUTS -5.54%

GXGXW 41.67%

GYRE -7.16%

HALO -1.39%

HARP 0.09%

HCWB -3.75%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -0.31%

HOOK -0.02%

HOTH -2.70%

HOWL -2.14%

HRMY 0.66%

HRTX 3.28%

HSTO 0.00%

HUMA 0.81%

HUMAW -0.01%

IBRX -4.52%

ICCC 0.22%

ICPT 0.21%

ICU 15.25%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.61%

IFRX -1.85%

IGMS -0.44%

IKNA 1.19%

IKT 1.42%

IMAB -0.29%

IMCR -3.36%

IMGN 0.02%

IMGO 0.00%

IMMP 5.70%

IMMX -7.33%

IMNM -1.65%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX -0.35%

IMTX -1.67%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.93%

INAB 0.00%

INBX 0.53%

INCY -0.89%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM 2.76%

INMB 2.60%

INO -2.34%

INSM -1.28%

INTS -2.75%

INVA 0.22%

INZY 0.68%

IOBT -11.76%

IONS 0.18%

IOVA -2.43%

IPA 2.50%

IPHA 5.58%

IPSC -2.15%

IRON -2.52%

ISEE 0.38%

ITOS -1.90%

ITRM 1.67%

IVA 6.96%

IVVD -2.07%

JAGX 1.05%

JANX -4.15%

JAZZ -0.77%

JNCE 0.00%

JSPR -6.20%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.54%

KALV -1.99%

KDNY 0.22%

KMPH -0.34%

KNSA -2.90%

KNTE -0.38%

KOD -7.11%

KPRX 0.96%

KPTI -1.38%

KRBP -10.00%

KRON 1.05%

KROS -1.38%

KRRO -8.23%

KRTX 0.03%

KRYS -1.01%

KTRA 15.96%

KTTA 8.16%

KTTAW 0.92%

KURA -1.46%

KYMR -2.54%

KYTX -4.26%

KZIA 2.65%

KZR -0.93%

LABP 0.57%

LBPH -2.62%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.82%

LENZ -3.73%

LEXX 1.16%

LEXXW -14.63%

LGND -1.30%

LGNDV 0.00%

LGVN -10.07%

LIAN -8.28%

LIFE 2.70%

LIPO -11.13%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 1.22%

LPCN -3.01%

LPTX -1.65%

LQDA -0.94%

LRMR -2.21%

LSTA -4.06%

LTRN 1.37%

LUMO -1.32%

LVTX -1.01%

LXEO -4.21%

LXRX -2.06%

LYEL -33.58%

LYRA 1.16%

MACK 0.10%

MBIO -10.60%

MBRX -2.57%

MCRB 3.01%

MDGL -3.53%

MDNA -13.16%

MDWD -0.27%

MDXG -2.80%

MEIP -0.13%

MESO -2.08%

MGNX -3.03%

MGTA -7.74%

MGTX -3.56%

MGX 0.54%

MIRM -1.90%

MIRO 0.59%

MIST 0.76%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -0.50%

MLYS -7.16%

MNKD -1.34%

MNMD 0.31%

MNOV 2.11%

MNPR -5.01%

MOLN 0.28%

MOR 1.29%

MORF -3.34%

MREO -4.56%

MRKR 2.68%

MRNA -5.28%

MRNS -4.40%

MRSN -2.15%

MRTX -0.17%

MRUS 0.18%

MRVI -1.82%

MTCR -1.29%

MTEM 4.95%

MTP -18.50%

MURA -0.93%

MYMD 5.41%

NAMS 2.03%

NAMSW 0.43%

NAUT 1.56%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.82%

NERV -0.63%

NEXI 2.60%

NGM -1.28%

NGNE -1.93%

NKGN 10.62%

NKGNW 8.00%

NKTR -4.19%

NKTX -5.22%

NLSP 7.59%

NLSPW 26.67%

NMRA -2.97%

NMTR -42.97%

NOVN -24.84%

NRBO 9.15%

NRIX -0.48%

NRSN -6.31%

NRSNW 0.00%

NRXP -5.20%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -5.71%

NTRBW -31.07%

NUVL -1.82%

NVAX -2.64%

NVCT 2.89%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 0.26%

OABIW -10.06%

OBIO -3.36%

OBSV 0.00%

OCEA 0.00%

OCGN 3.81%

OCS -1.00%

OCUL -1.83%

OCUP 1.30%

ODT -4.27%

OKYO 1.51%

OLMA -6.05%

OMER -0.51%

OMGA 4.56%

ONCO 4.96%

ONCR -3.08%

ONCS 31.87%

ONCT -3.05%

ONCY -0.99%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 2.06%

ORGS 0.67%

ORIC -3.42%

ORMP 21.38%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -2.36%

OVID -1.44%

OYST 0.00%

PALI 2.58%

PASG -1.30%

PBLA -7.50%

PBM -4.89%

PBYI 1.35%

PCSA 0.00%

PCVX -0.59%

PDSB -3.01%

PEPG 2.62%

PGEN -2.99%

PHAR 1.51%

PHAS 0.00%

PHAT -1.55%

PHIO -3.57%

PHIOW 36.47%

PHVS -6.85%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -1.37%

PLUR 6.01%

PMN 0.72%

PMVP -0.30%

PNT 0.16%

PPBT -10.93%

PRAX 0.37%

PRDS 0.93%

PRLD -3.17%

PROG -3.47%

PROK -0.37%

PRQR -0.01%

PRTA -2.74%

PRTC 0.49%

PRTG -0.54%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -7.32%

PSTX -1.16%

PTCT -0.65%

PTE -0.82%

PTGX -1.80%

PTIXW -49.04%

PULM 2.60%

PXMD 0.00%

PYPD 0.07%

PYXS 1.63%

QLGN -4.39%

QNCX 5.70%

QNRX 0.37%

QSI -11.97%

QSIAW -3.13%

QTTB -1.83%

QURE -0.84%

RAIN -1.63%

RANI 6.42%

RAPT -3.57%

RARE 1.15%

RCKT -8.22%

REGN -0.45%

RENB -3.10%

REPL -2.95%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 4.38%

RGLS -5.37%

RGNX -5.93%

RIGL -3.29%

RLAY -4.15%

RLMD 0.33%

RLYB -0.34%

RNA -0.09%

RNAC -5.94%

RNAZ -0.96%

RNXT 1.88%

ROIV -2.17%

ROIVW 4.56%

RPHM -0.31%

RPRX 0.13%

RPTX -2.35%

RUBY 2.70%

RVLP -32.05%

RVMD -1.25%

RVMDW -30.00%

RVNC 1.70%

RVPH -1.61%

RVPHW 1.62%

RXDX 0.09%

RXRX -3.52%

RYTM -6.74%

RYZB 0.02%

RZLT 1.16%

SABS -1.37%

SABSW -11.81%

SAGE 1.74%

SANA -4.06%

SAVA -0.73%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH 2.40%

SCPS 0.00%

SEEL -3.63%

SEER 0.59%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO 0.20%

SGMT -2.17%

SGTX -2.56%

SIOX 22.63%

SLDB -5.69%

SLGL 2.97%

SLN -4.76%

SLNO -4.21%

SLRX 6.07%

SLS -2.14%

SMMT -2.62%

SNDX 1.13%

SNGX -3.40%

SNPX -3.73%

SONN -1.08%

SPPI -0.49%

SPRB 1.52%

SPRC -2.75%

SPRO 0.05%

SRNE -34.00%

SRPT -1.30%

SRRA 0.00%

SRRK -2.48%

SRZN -2.45%

STAB 0.00%

STOK -5.27%

STRO -3.01%

STSA 0.00%

STTK -2.95%

SURF -0.93%

SVRA -5.14%

SWTX -0.03%

SYBX -1.94%

SYRS -1.03%

TALS -0.73%

TARA -7.98%

TARS -0.56%

TBPH 0.60%

TCBP 2.47%

TCDA 0.00%

TCON 0.68%

TCRR 0.00%

TCRT 1.59%

TCRX 1.45%

TECH -0.16%

TENX -1.27%

TERN -7.85%

TFFP -5.21%

TGTX -3.23%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -2.11%

TNGX -2.76%

TNXP -4.81%

TNYA -6.83%

TPST 3.33%

TRDA -4.61%

TRVI 2.30%

TRVN 2.97%

TSHA -24.94%

TSVT -3.46%

TTNP -9.27%

TVTX 0.50%

TYRA -7.54%

UBX -2.12%

UNCY -3.90%

URGN -1.51%

UTHR -0.48%

VACC 11.36%

VALN -2.89%

VAXX 68.75%

VBIV 0.78%

VBLT -8.77%

VCEL -0.42%

VCNX 10.35%

VCYT -1.03%

VERA -3.83%

VERU -0.57%

VERV -2.96%

VIGL 7.53%

VINC 3.00%

VIR 0.76%

VIRI -1.61%

VIRX 2.40%

VKTX -1.32%

VLON -13.04%

VNDA -2.69%

VOR -2.02%

VRCA 0.00%

VRDN -4.39%

VRNA -1.66%

VRPX 0.38%

VRTX 0.32%

VSTM -2.38%

VTGN -1.05%

VTVT -2.97%

VTYX -1.26%

VXRT -3.85%

VYGR -0.51%

VYNE -4.35%

VYNT 7.78%

WINT -3.24%

WVE -4.50%

XBIO 0.93%

XBIT -2.70%

XCUR 3.58%

XENE -3.14%

XERS 2.14%

XFOR 2.08%

XLO 4.54%

XLRN 0.00%

XNCR 0.36%

XOMA -2.94%

XOMAO 0.36%

XOMAP -0.82%

XRTX -8.00%

YMAB -1.96%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.97%

ZNTL -0.71%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-06-03	Bienaime Jean Jacques	Buy	17 600	Stock Option (right to buy)
2024-06-01	Bienaime Jean Jacques	Sell	0	Common Stock
2024-05-30	Seth Alpna	Buy	10 000	Stock Option (right to buy)
2024-05-30	Kariv Tomer	Buy	10 000	Stock Option (right to buy)
2024-05-30	Nussbaum Ran	Buy	10 000	Stock Option (right to buy)

INSIDER POWER
72.50
Last 96 transactions
Buy: 1 315 963 \| Sell: 331 750

Correlation (AI algo v.1.1b): Overvalued: -0.05% $45.04 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: 0.41 (neutral)

Short: 0.53 (weak)

Signal:(45.291) Neutral

Keros Therapeutics Inc Correlation

10 Most Positive Correlations
UNCY	0.907
SWTX	0.896
ENSG	0.888
PPH	0.879
ADAP	0.872
TARA	0.87
KNSL	0.869
IMNM	0.868
ASND	0.868
FULC	0.858

10 Most Negative Correlations
BLKB	-0.878
MYNA	-0.872
RELL	-0.87
AUR	-0.853
MYFW	-0.838
KTRA	-0.835
BSGM	-0.831
FLNC	-0.817
COCP	-0.816
PLBC	-0.816

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Keros Therapeutics Inc Correlation - Currency/Commodity

-0.36
( neutral )

-0.52
( weak negative )

0.00
( neutral )

-0.37
( neutral )

-0.39
( neutral )

0.50
( neutral )

Keros Therapeutics Inc Financials

Annual	2023
Revenue:	$151 000
Gross Profit:	$-664 000 (-439.74 %)
EPS:	$-5.20

FY	2023
Revenue:	$151 000
Gross Profit:	$-664 000 (-439.74 %)
EPS:	$-5.20

FY	2022
Revenue:	$0
Gross Profit:	$-1.62M (0.00 %)
EPS:	$-4.15

FY	2021
Revenue:	$20.10M
Gross Profit:	$0.00 (0.00 %)
EPS:	$-2.52

Financial Reports:

No articles found.

Keros Therapeutics Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Keros Therapeutics Inc

Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia in patients with myelodysplastic syndromes, and in patients with myelofibrosis. It is also developing small molecule product candidate KER-047 that is being developed for the treatment of anemia, and is currently in Phase 1 clinical trial; and KER-012, which is in Phase 1 clinical trial to treat disorders associated with bone loss, such as osteoporosis and osteogenesis imperfecta, and for the treatment of pulmonary arterial hypertension. The company was incorporated in 2015 and is headquartered in Lexington, Massachusetts.